583 Safety of peginterferon α-2a (40KD) (PEGASYS®) [PEG-IFNα-2a (40KD)] plus ribavirin (COPEGUS®) among pegylated interferon α-2b (12KD)/ribavirin non-responders: Interim analysis of the repeat study